Product leader, fitness operator, and AI founder. Former Head of Product at Freeletics, now building Fuel.

Stephen is the founder of Fuel and writes most of the Fuel Journal. He builds nutrition coaching for the same audience he has shipped products to for a decade: people who take training seriously and want software that respects it.
From 2017 to 2020 he led product, design, research, content, and subscription monetization as Head of Product & Design at Freeletics, where his teams helped the digital fitness app surpass 50 million users worldwide across 100+ countries, with 70% week-one training activation. That stint — owning every surface that touches habit formation in a fitness app — is the operator lens behind every article here.
After Freeletics he grew Productboard 5x to $50M+ ARR as Senior Director of Product Management (2020–2022), reshaping the product from SMB/PLG-darling to enterprise roadmap software adopted by 6,000+ companies. Since 2022 he has been co-founder and CEO of Klu.ai, an LLM infrastructure platform used by thousands of AI teams — which is why Fuel's AI food logging and coaching feel less hand-wavy than most.
Earlier he ran global UX programs at Amazon (2016–2017) for cross-border eCommerce, led mobile investing design at Capital One (2014–2016), and spent a decade (2003–2014) running Smoov, a boutique design studio shipping work across consoles, desktop, mobile, and web. He speaks regularly at EU CPO Conference, SXSW, La Product Conf, and Product Led Alliance. Verifiable on SMW.ai, LinkedIn, and Speaker Deck.
A 2025 meta-analysis found a cortisol drop of 1.16 µg/dL and no significant change in perceived-stress scores. Use this decision guide for extract, dose, a 6 to 8 week trial, and the liver and thyroid stop rules.
Imaging shows percent visceral fat often falls faster than percent abdominal subcutaneous fat during modest weight loss. Aerobic work can cut VAT even when scale weight holds. Rank the deficit, cardio, lifting, alcohol, liquid sugar, and sleep, then track waist under a fixed protocol.
Semaglutide and tirzepatide dose increases use scheduled minimum intervals. Intake, protein, and rate-of-loss trends add nutrition context before each decision.
Late eating can affect hunger and energy expenditure. Controlled trials explain what that means for fat loss, meal timing, training, and reflux.
Leucine research, flexible dieting, metabolic adaptation, and the seed oil debate, drawn from Dr. Layne Norton's own published research and long-form interviews.
256 articles in the Fuel Journal, newest first.
